Your Health. Your Family. Your Choice.
Administered by: Private Purchased by: Private
Life Threatening? No
Write-up: Information has been received from a nurse concerning a 19 year old female with no pertinent medical history or drug reactions allergies who on 8/15/06 was vaccinated IM with the first dose of HPV rL1 6 11 16 18 VLP vaccine yeast (lot 653650/0702F). Concomitant therapy included Menactra. On an unspecified date the pt was given tuberculin purified protein derivative. On 8/15/06, 5 minutes after vaccination with HPV rL1 6 11 16 18 VLP vaccine yeast, the pt became faint. The pt was given water and chocolate as treatment. Subsequently, the pt recovered on 8/15/06. Additional information has been requested. 01/05/2007 Initial and follow-up information has been received from a nurse concerning a 19 year old female patient with no pertinent medical history or drug reactions/allergies who on 15-AUG-2006 at 9:00 AM was vaccinated intramuscularly with the first dose of GARDASIL (lot #653650/0702F). Concomitant therapy included "MENACTRA". On an unspecified date the patient was given tuberculin purified protein derivative. On 15-AUG-2006, within 10 minutes of receiving the vaccination, the patient became very faint and sweaty which lasted for approximately 60 seconds. The patient remained in the office for 45 minutes and was given water and chocolate as treatment. Subsequently, the patient recovered on 15-AUG-2006. No further information is expected.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166